Prophylactic strategies for hand-foot syndrome/skin reaction associated with systemic cancer treatment: a meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Prophylactic strategies for hand-foot syndrome/skin reaction associated with systemic cancer treatment: a meta-analysis of randomized controlled trials

Published:2022-06-02 Issue:11 Volume:30 Page:8655-8666
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Pandy Jessa Gilda P.^ORCID,Franco Paula Isabel G.,Li Rubi K.

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

https://link.springer.com/content/pdf/10.1007/s00520-022-07175-3.pdf

Reference33 articles.

1. Yap Y, Kwok L, Syn N et al (2017) Predictors of hand-foot syndrome and pyridoxine for prevention of capecitabine–induced hand-foot syndrome: a randomized clinical trial. JAMA Oncol 3(11):1538–1545. https://doi.org/10.1001/jamaoncol.2017.1269

2. Nikolaou V, Syrigos K, Saif MW (2016) Incidence and implications of chemotherapy related hand-foot syndrome. Expert Opin Drug Saf 15(12):1625–1633. https://doi.org/10.1080/14740338.2016.1238067

3. Degen A, Alter M, Schenck F et al (2010) The hand-foot-syndrome associated with medical tumor therapy - classification and management. J Dtsch Dermatol Ges 8(9):652–661. https://doi.org/10.1111/j.1610-0387.2010.07449.x

4. Macedo LT, Lima JP, dos Santos LV, Sasse AD (2014) Prevention strategies for chemotherapy-induced hand-foot syndrome: a systematic review and meta-analysis of prospective randomised trials. Support Care Cancer 22(6):1585–1593. https://doi.org/10.1007/s00520-014-2129-z

5. Yadav N, Madke B, Kar S, Prasad K (2015) Liposomal doxorubicin-induced palmoplantar erythrodysthesia syndrome. Indian Dermatol Online J 6(5):366–368. https://doi.org/10.4103/2229-5178.164488

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Randomized controlled trial on the efficacy of topical urea-based cream in preventing capecitabine-associated hand-foot syndrome;2024-08-09

2. Evaluation of the impact of systemic dexamethasone dosage on docetaxel-induced hand-foot syndrome in patients with breast cancer;Scientific Reports;2024-06-18

3. Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled Trial;Journal of Clinical Oncology;2024-05-20

4. Capecitabine-induced hand foot syndrome: a brief look at possible pathways that may be associated with inflammation;ODÜ Tıp Dergisi;2024-04-30

5. The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus;Supportive Care in Cancer;2023-11-04